Ever Supreme Bio Technology Co. Ltd.

04/30/2024 | Press release | Distributed by Public on 04/30/2024 01:42

Announcement of the Company’s list of newly elected directors (including independent directors)

Close
Today's Information

Provided by: Ever Supreme Bio Technology Co., Ltd
SEQ_NO 2 Date of announcement 2024/04/30 Time of announcement 15:39:35
Subject
 Announcement of the Company's list of newly elected
directors (including independent directors)
Date of events 2024/04/30 To which item it meets paragraph 6
Statement
1.Date of occurrence of the change:2024/04/30
2.Elected or changed position (Please enter institutional
director, institutional supervisor, independent director,
natural-person director or natural-person supervisor):
 Institutional director, independent director, natural-person director.
3.Title and name of the previous position holder:
  (1)Director: Liu Chu-Chi
  (2)Director: Huang Wen-Liang
  (3)Director: AnJi Bio Co., Ltd.
  (4)Director: He Shi-Jun
  (5)Director: Center Laboratories, Inc.
  (6)Independent Director: Chen Jin-Long
  (7)Independent Director: Chen Wen-Hou
  (8)Independent Director: Lu Hui-Ming
4.Resume of the previous position holder:
  (1)Director: Liu Chu-Chi, The Company President
  (2)Director: Huang Wen-Liang, The Compnay GM
  (3)Director: AnJi Bio Co., Ltd., The Company Director
  (4)Director: He Shi-Jun, Director of TRADE-VAN INFORMATION
     SERVICES CO.
  (5)Director: Center Laboratories, Inc., The Company Director
  (6)Independent Director: Chen Jin-Long, J.Yeu law office
  (7)Independent Director: Chen Wen-Hou, Taiwan Medical Association
     Directors
  (8)Independent Director: Lu Hui-Ming, Lu Hui-min Certified
     Public Accountants (CPA) Office Director
5.Title and name of the new position holder:
  (1)Director: Liu Chu-Chi
  (2)Director: Huang Wen-Liang
  (3)Director: AnJi Bio Co., Ltd.
  (4)Director: He Shi-Jun
  (5)Director: Center Laboratories, Inc.
  (6)Independent Director: Chen Jin-Long
  (7)Independent Director: Chen Wen-Hou
  (8)Independent Director: Lu Hui-Ming
6.Resume of the new position holder:
  (1)Director: Liu Chu-Chi, The Company President
  (2)Director: Huang Wen-Liang, The Compnay GM
  (3)Director: AnJi Bio Co., Ltd., The Company Director
  (4)Director: He Shi-Jun, Director of TRADE-VAN INFORMATION
     SERVICES CO.
  (5)Director: Center Laboratories, Inc., The Company Director
  (6)Independent Director: Chen Jin-Long, J.Yeu law office
  (7)Independent Director: Chen Wen-Hou, Taiwan Medical Association
     Directors
  (8)Independent Director: Lu Hui-Ming, Lu Hui-min Certified
     Public Accountants (CPA) Office Director
7.Circumstances of change (Please enter "resignation", "dismissal",
"term expired", "death" or "new appointment"):term expired
8.Reason for the change:term expired
9.Number of shares held by the new position holder when elected:
  (1)Director: Liu Chu-Chi, 1,122,010 shares
  (2)Director: Huang Wen-Liang, 568,697 shares
  (3)Director: AnJi Bio Co., Ltd., 10,386,167 shares
  (4)Director: He Shi-Jun, 857,011 shares
  (5)Director: Center Laboratories, Inc., 8,912,563 shares
  (6)Independent Director: Chen Jin-Long, 0 shares
  (7)Independent Director: Chen Wen-Hou, 0 shares
  (8)Independent Director: Lu Hui-Ming, 0 shares
10.Original term (from __________ to __________):2021/07/06 ~ 2024/07/05
11.Effective date of the new appointment:2024/04/30
12.Turnover rate of directors of the same term:N/A
13.Turnover rate of independent directors of the same term:N/A
14.Turnover rate of supervisors of the same term:N/A
15.Change in one-third or more of directors (Please enter "Yes" or
"No"):No.
16.Any other matters that need to be specified(the information
 disclosure also meets the requirements of Article 7, subparagraph 6
 of the Securities and Exchange Act Enforcement Rules, which brings
 forth a significant impact on shareholders rights or the price of
 the securities on public companies.):None.